Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.410
+0.060 (4.44%)
Apr 15, 2026, 4:00 PM EDT - Market closed
Lucid Diagnostics Revenue
In the year 2025, Lucid Diagnostics had annual revenue of $4.71M with 8.28% growth. Lucid Diagnostics had revenue of $1.50M in the quarter ending December 31, 2025, with 25.65% growth.
Revenue (ttm)
$4.71M
Revenue Growth
+8.28%
P/S Ratio
51.04
Revenue / Employee
$57,390
Employees
82
Market Cap
240.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.71M | 360.00K | 8.28% |
| Dec 31, 2024 | 4.35M | 1.92M | 79.00% |
| Dec 31, 2023 | 2.43M | 2.05M | 544.03% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| InfuSystem Holdings | 143.44M |
| RxSight | 134.48M |
| Sight Sciences | 77.36M |
| Electromed | 68.86M |
| CVRx, Inc. | 56.65M |
| 908 Devices | 56.20M |
| TriSalus Life Sciences | 45.15M |
LUCD News
- 6 days ago - Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 13 days ago - PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - PRNewsWire
- 16 days ago - PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 20 days ago - Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 4 weeks ago - PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026 - PRNewsWire
- 4 weeks ago - Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - PRNewsWire
- 2 months ago - PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PRNewsWire
- 3 months ago - Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - PRNewsWire